Gynecologic surgeon Mario Leitao commented on a study that suggests that testing for HPV may be a better way to predict whether a woman is at risk of developing cervical cancer than a traditional Pap test.
Gynecologic surgeon Carol Brown commented on a study that shows that the infection rate of human papillomavirus (HPV), the main cause of cervical cancer, decreased by 56 percent since the HPV vaccine was introduced in 2006.
Gynecologic Medical Oncology Service Chief Carol Aghajanian applauded a study that showed that using vinegar to screen for cervical cancer is an effective, low-cost alternative to the Pap smear and can help reduce the burden of disease in developing countries.
Minority patients have a significantly decreased survival from colon cancer compared to white patients, most often as a result of a late diagnosis. To help address this problem, a team of healthcare professionals at Memorial Sloan Kettering Cancer Center has identified an efficient way to increase minority access to lifesaving colorectal cancer screening (CRCS) in communities where multiple barriers to preventive care exist.
Dr. Barakat will serve as president of two prestigious societies for gynecologic cancer, allowing him to influence how women with these cancers are cared for both in the United States and around the world.
Medical oncologist Paul Sabbatini, a specialist in treating gynecologic cancers, leads a clinical research program seeking to improve treatments for ovarian cancer by harnessing the power of the immune system.
Memorial Sloan Kettering physicians Yukio Sonoda and Nadeem Abu-Rustum were joined by cancer survivors and their children to celebrate 10 years of Memorial Sloan Kettering’s radical trachelectomy program.